Loading clinical trials...
Loading clinical trials...
aGVHD remains as complication in patients after allogeneic stem cell transplantation. Methylprednisolone at 1\~2mg/kg is considered as standard first-line treatment. In recent lab study, we demonstrat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators
NCT05436418 · Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation
NCT05153226 · Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, and more
NCT07440654 · aGVHD Prophylaxis
NCT04745637 · Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), and more
NCT04061876 · aGVHD, Stem Cell Transplant Complications
Blood & Marrow Transplantation Center, RuiJin Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions